FGFR2 Genetic Alterations
1 clinical trials · Condition
◉ Watch FGFR2 Genetic Alterations
| Record | Firm | Date |
|---|---|---|
| A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors (NCT06777316) | Cogent Biosciences, Inc. | 2025-01-22 |
Track FGFR2 Genetic Alterations automatically
Every clearance here is in the API, with alerts when new ones post.